Flurazepam

DB00690ApprovedIllicitSmall moleculeBenzodiazepines and benzodiazepine derivatives

Flurazepam is a long-acting benzodiazepine with a rapid onset of action that is commonly used to treat insomnia. A benzodiazepine derivative used mainly as a hypnotic.

Chemical structure of Flurazepam
Mechanism
Curator reviewed
Primary indication
For short-term and intermittent use in patients with recurring insomnia and poor sleeping habitsCurator reviewed · 1 structured indication
Formula / weight
C21H23ClFN3O · 387.878 g/mol (avg)
First approval
Canada, 1997 · United States, 1985
Code names
ID 480 · Ro 5-6901
Brand names
  • Dalmane

Resolves to

Structure
InChIKeySAADBVWGJQAEFS-UHFFFAOYSA-NSMILESCCN(CC)CCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F
Targets

What you can answer from here — as of September 23, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
2TransportersSubstrate / inhibitor direction, not just membership
Listed above
1,716Drug interactionsStructured to mechanism, not free text
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
2ContraindicationsEach with its own population and attribute set
Sign in
55Marketed productsAcross 4 countries and 27 labellers
Sign in
1ATC codeIncluding every combination product, plus 27 drug categories
Sign in
19+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Flurazepam, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account